A study identified a protein that stalls myelin repair in the brain, suggesting that targeting it could be a strategy for MS treatment.

Research published in the Journal of Neurochemistry has detailed the role of a protein, hnRNP A1, in the formation and stability of myelin, suggesting an important impact on neurodegenerative diseases ...